Detalhe da pesquisa
1.
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).
BJU Int
; 133(6): 680-689, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469686
2.
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
BMC Cancer
; 22(1): 220, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227226
3.
Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies.
World J Urol
; 39(4): 1153-1159, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472278
4.
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
BMC Cancer
; 20(1): 488, 2020 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473650
5.
Tumour heterogeneity poses a significant challenge to cancer biomarker research.
Br J Cancer
; 117(3): 367-375, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618431
6.
Increased magnetic resonance imaging in prostate cancer management-What are the outcomes?
J Eval Clin Pract
; 29(6): 893-902, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36374190
7.
Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Scand J Urol
; 58: 133-140, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116675
8.
Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry.
BJUI Compass
; 4(3): 331-338, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025477
9.
Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.
Scand J Urol Nephrol
; 46(2): 108-16, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22087730
10.
[What are many and when is it enough?]. / Hva er mange og når er det nok?
Tidsskr Nor Laegeforen
; 137(7): 505, 2017 04.
Artigo
em Norueguês
| MEDLINE | ID: mdl-28383213
11.
No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance.
Sci Rep
; 12(1): 6743, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468921
12.
Predictors of upgrading from low-grade cancer at prostatectomy in men with biparametric magnetic resonance imaging.
Cent European J Urol
; 75(1): 35-40, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35591966
13.
Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging-detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score.
Eur Urol
; 82(5): 559-568, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963650
14.
[Re: Circumcision of boys]. / Re: Omskjæring av gutter.
Tidsskr Nor Laegeforen
; 136(1): 9, 2016 Jan 12.
Artigo
em Norueguês
| MEDLINE | ID: mdl-26757642
15.
Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy.
Diagn Pathol
; 16(1): 109, 2021 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34809660
16.
Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance.
Eur Urol Open Sci
; 25: 44-51, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337502
17.
Which data are available in central registries on bladder cancer patients in the five Nordic countries.
Scand J Urol
; 55(2): 135-141, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504267
18.
TECLA-an innovative technical approach for prostate cancer registries.
Scand J Urol
; 53(4): 229-234, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264501
19.
Bladder cancer survival: Women better off in the long run.
Eur J Cancer
; 95: 52-58, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29635144
20.
High Norwegian prostate cancer mortality: evidence of over-reporting.
Scand J Urol
; 52(2): 122-128, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325479